This phase III , double-blind , placebo-controlled , parallel-group study randomized @ patients with moderate to severe pain ( @ intensity on an @ point numeric rating scale ) following total knee replacement arthroplasty to receive oral TA-ER ( every @ hours ) or TA-IR ( every @ hours ) over a period of @ hours .